These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36239872)

  • 1. Short- and long-term outcomes in ypT2 rectal cancer patients after neoadjuvant therapy and local excision: a multicentre observational study.
    Peltrini R; Castiglioni S; Imperatore N; Ortenzi M; Rega D; Romeo V; Caracino V; Liberatore E; Basti M; Santoro E; Bracale U; Delrio P; Mucilli F; Guerrieri M; Corcione F
    Tech Coloproctol; 2023 Jan; 27(1):53-61. PubMed ID: 36239872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transanal Endoscopic Microsurgery for Early Rectal Cancer: A Single-Center Experience.
    O'Neill CH; Platz J; Moore JS; Callas PW; Cataldo PA
    Dis Colon Rectum; 2017 Feb; 60(2):152-160. PubMed ID: 28059911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 5. Local excision for ypT2 rectal cancer following preoperative chemoradiation therapy: it should not be justified.
    Yang KM; Lim SB; Lee JL; Kim CW; Yoon YS; Park IJ; Yu CS; Kim JC
    Int J Colorectal Dis; 2018 Apr; 33(4):487-491. PubMed ID: 29468352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
    Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
    Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transanal local excision versus intersphincteric resection for low rectal cancer with stage ypT0-1ycN0 after neoadjuvant chemoradiotherapy: an inverse probability weighting analysis for oncological and functional outcomes.
    Pan H; Gao Y; Ruan H; Chi P; Huang Y; Huang S
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17383-17394. PubMed ID: 37843558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local excision for ypT2 rectal cancer--much ado about something.
    Perez RO; Habr-Gama A; Proscurshim I; Campos FG; Kiss D; Gama-Rodrigues J; Cecconello I
    J Gastrointest Surg; 2007 Nov; 11(11):1431-8; discussion 1438-40. PubMed ID: 17805938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
    Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
    Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
    Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer.
    Stipa F; Picchio M; Burza A; Soricelli E; Vitelli CE
    Dis Colon Rectum; 2014 Nov; 57(11):1245-52. PubMed ID: 25285690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study).
    Verseveld M; de Graaf EJ; Verhoef C; van Meerten E; Punt CJ; de Hingh IH; Nagtegaal ID; Nuyttens JJ; Marijnen CA; de Wilt JH;
    Br J Surg; 2015 Jun; 102(7):853-60. PubMed ID: 25847025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer.
    González JEB; Lavernia HC; Fraga JGP; Lemus SQ
    Surg Endosc; 2022 May; 36(5):2906-2913. PubMed ID: 34231071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer.
    Coco C; Delrio P; Rega D; Amodio LE; Pucciarelli S; Spolverato G; Belluco C; Lauretta A; Poggioli G; Rocco G; Bianco F; Marsanic P; Sica G; Tondolo V; Rizzo G;
    Colorectal Dis; 2024 Feb; 26(2):281-289. PubMed ID: 38131642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer.
    Borschitz T; Wachtlin D; Möhler M; Schmidberger H; Junginger T
    Ann Surg Oncol; 2008 Mar; 15(3):712-20. PubMed ID: 18163173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study.
    Liao YT; Lin YL; Huang J; Hung JS; Lin BR
    Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of the rectum is possible in early rectal cancer with neoadjuvant radiotherapy, delay and local excision-a 12-year single-centre experience of the evolution of early rectal cancer treatment.
    Bilkhu A; Robinson JM; Steward MA
    Colorectal Dis; 2021 Jul; 23(7):1765-1776. PubMed ID: 33724612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
    Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
    Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.